Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-05-03T22:45:28.906Z Has data issue: false hasContentIssue false
  • English
  • Français

Persistence of poliovirus-neutralizing antibodies 2–16 years after immunization with live attenuated vaccine. A seroepidemiologic survey in the mainland of Venice.

Published online by Cambridge University Press:  15 May 2009

R. Trivello ,
G. Renzulli ,
G. Farisano ,
C. Bonello ,
M. Moschen ,
V. Gasparini  and
G. Benussi
R. Trivello
Affiliation:
School of Hygiene and Preventive Medicine, University of Padua, Italy
G. Renzulli
Affiliation:
School of Hygiene and Preventive Medicine, University of Padua, Italy
G. Farisano
Affiliation:
Laboratory of Clinical Chemistry and Immunology, Hospital of Dolo (Venice), Italy
C. Bonello
Affiliation:
Laboratory of Clinical Chemistry and Immunology, Hospital of Dolo (Venice), Italy
M. Moschen
Affiliation:
University of Verona, Italy
V. Gasparini
Affiliation:
School of Hygiene and Preventive Medicine, Trieste, Italy
G. Benussi
Affiliation:
School of Hygiene and Preventive Medicine, Trieste, Italy
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A seroepidemiological survey was conducted on subjects who had received a full vaccination course with live attenuated poliovirus 2–16 years before. For strains 1 and 2 prevalence of seropositives and median values dropped gradually during the first 10 years; strain 3 showed a much earlier decline. Environmental displacement of wild poliovirus by the attenuated, less immunogenic strain might eventually induce a ‘gap’, should complacency hamper needed vaccination efforts.

Type
Research Article
Information
Epidemiology & Infection , Volume 101 , Issue 3 , December 1988 , pp. 605 - 610
Copyright
Copyright © Cambridge University Press 1988

References

REFERENCES

Böttiger, M., Mellin, P., Romanus, V. & Söderström, H. (1972). Seroimmunity to poliomyelitis in Sweden after the use of inactivated polioviurs vaccine for 10 years. Bulletin of the World Health Organization 46. 141–149.Google Scholar
Campello, C., Dal, Molin G. & Majori, L. (1985). Polioparalisi da vaccinazione: descrizione diun caso e considerazioni su aspetti attuali della vaccinazione antipoliomielite. Igiene Moderna.Google Scholar
Giannico, L. (1983). Vaccinazione antipoliomielitica: il punto sulla situazione. Atti del XIX Congresso di medicina Sociale. Garda, Italy.Google Scholar
Hopkins, C. C., Dismukes, W. C. & Glick, T. H. (1969). Surveillance of paralytic poliomyelitis in the United States. Journal of the American Medical Association 210, 694–700.Google Scholar
Hoskins, J. M. (1969). Assay of antibody by neutralization. In Virological Procedures. pp. 236–240. London: Butterworth.Google Scholar
Istituto Centrale De Statistica. (1976). Sommario di Statistiche Storiche dell'italia 1961–1975. p. 41. Rome.Google Scholar
Majori, L., Campello, C. & Cattaruzza, A. (1978). Preliminary observations on viral pollution on mussels taken from the coastal seawaters of the Gulf of Trieste. IV Journee Etudes Pollution. Antalya C.I.E.S.M. pp. 511–516.Google Scholar
Melnick, J. L. (1982)Enterviruses. In Viral Infetions in Humans. Epidemiology and control (Ed. Evans, A. S). New York: Plenum Medical Book Co.Google Scholar
Melnick, J. L.., Burkhardt, M. & Taber, L. H. (1969). Developing a gap in immunity to poliomyelitis in an urban area. Journal of the American Medical Association 209, 1181–1185.Google Scholar
Moore, M., Katona, P., Kaplan, J. E. & Schonberger, L. B. (1982). Poliomyelitis in the United States. 1969–1981. Journal of Infectious Diseases 146, 558–563.Google Scholar
Moschen, M., Trivello, R., Gasparini, V., Farisano, G., Bonello, C., Benussi, G., Barbone, F. & Renzulli, G. (1985). Prevalence of poliovirus neutralizing antibodies. A seroepidemiologic survey of vaccinated and unvaccinated women of fertile age. Bollettino dell Istituto Sieroterapico Milanese.Google Scholar
Nightingale, E. O. (1977). Recommendations for a national policy on poliomyelitis vaccination. New England Journal of Medicine 297, 249–253.Google Scholar
Piazza, M., Picciotto, L., Tiseo, D. & Gaudagnino, V. (1983). Seroimmunity to polioviruses in the Naples area. Giornale di Malattie Infettive e Parassitarie 35, 274–278.Google Scholar
Rasmussen, C. M., Thomas, C. W., Mulrooney, R. J. & Morrisey, R. A. (1973). Inadequate poliovirus immunity levels in immunized Illinois children. American Journal of Diseases in Childhood 126, 465–469.Google Scholar
Rousseau, W. E., Noble, G. R., Tegtmeier, G. E., Jordan, M. C. & Chin, T. D. Y. (1973). Persistence of poliovirus neutralizing antibodies eight years after immunization with live, attenuated virus vaccine. New England journal of Medicine 289, 1357–1359.Google Scholar
Weekly Epidemiological Record (1982). Paralysis associated with poliomyelitis vaccine 57, 345–348.Google Scholar
World Health Organization (1976). The relation between acute spinal paralysis and poliomyelitis vaccine (oral). Results of a WHO enquiry. Bulletin of the World Health Organization 53, 319–331.Google Scholar